InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MBL | Ann: Macquarie Bank Releases June Pillar 3 Disclosure | 23/08/24 | 0 | 180 | |||
|
|||||||
MBL | Ann: Issue of A$1.25bn subordinated notes cleansing notice | 09:30 | 0 | 95 | |||
|
|||||||
MBL | Ann: Change of Director's Interest Notice | 06/08/24 | 0 | 120 | |||
|
|||||||
MBL | Ann: Change of Director's Interest Notice | 06/08/24 | 0 | 105 | |||
|
|||||||
MBL | Ann: Final Director's Interest Notice | 26/07/24 | 0 | 107 | |||
|
|||||||
MBL | Ann: Macquarie Group 2024 AGM Presentation | 25/07/24 | 1 | 248 | |||
|
|||||||
MBL | Ann: Macquarie Group 2024 Chair Address | 25/07/24 | 1 | 207 | |||
|
|||||||
MBL | Ann: Macquarie Group 2024 AGM Media Release | 25/07/24 | 0 | 161 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |